Sanford Shattil - Publications

Affiliations: 
Molecular Pathology University of California, San Diego, La Jolla, CA 
Area:
Cell Biology

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Kasirer-Friede A, Peuhu E, Ivaska J, Shattil SJ. Platelet SHARPIN regulates platelet adhesion and inflammatory responses through associations with αIIbβ3 and LUBAC. Blood Advances. PMID 34991155 DOI: 10.1182/bloodadvances.2021005611  0.356
2019 Kasirer-Friede A, Tjahjono W, Eto K, Shattil SJ. SHARPIN at the nexus of integrin, immune, and inflammatory signaling in human platelets. Proceedings of the National Academy of Sciences of the United States of America. PMID 30804189 DOI: 10.1073/pnas.1819156116  0.341
2018 Lagarrigue F, Gingras AR, Paul DS, Valadez AJ, Cuevas MN, Sun H, Lopez-Ramirez MA, Goult BT, Shattil SJ, Bergmeier W, Ginsberg MH. Rap1 binding to the talin 1 F0 domain makes a minimal contribution to murine platelet GPIIb-IIIa activation. Blood Advances. 2: 2358-2368. PMID 30242097 DOI: 10.1182/Bloodadvances.2018020487  0.348
2014 Kasirer-Friede A, Kang J, Kahner B, Ye F, Ginsberg MH, Shattil SJ. ADAP interactions with talin and kindlin promote platelet integrin αIIbβ3 activation and stable fibrinogen binding. Blood. 123: 3156-65. PMID 24523237 DOI: 10.1182/Blood-2013-08-520627  0.345
2014 Kato S, Seguin L, Franovic A, Kato H, Camargo M, Desgrosellier J, Anand S, Weis S, Shattil S, Cheresh DA. Abstract 4240: Targeting Galectin-3 to reverse tumor stemness and drug resistance Cancer Research. 74: 4240-4240. DOI: 10.1158/1538-7445.Am2014-4240  0.315
2010 Kasirer-Friede A, Ruggeri ZM, Shattil SJ. Role for ADAP in shear flow-induced platelet mechanotransduction. Blood. 115: 2274-82. PMID 19996090 DOI: 10.1182/blood-2009-08-238238  0.332
2008 Watanabe N, Bodin L, Pandey M, Krause M, Coughlin S, Boussiotis VA, Ginsberg MH, Shattil SJ. Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin alphaIIbbeta3. The Journal of Cell Biology. 181: 1211-22. PMID 18573917 DOI: 10.1083/Jcb.200803094  0.326
2007 Prévost N, Kato H, Bodin L, Shattil SJ. Platelet integrin adhesive functions and signaling. Methods in Enzymology. 426: 103-15. PMID 17697882 DOI: 10.1016/S0076-6879(07)26006-9  0.304
2007 Kasirer-Friede A, Kahn ML, Shattil SJ. Platelet integrins and immunoreceptors. Immunological Reviews. 218: 247-64. PMID 17624957 DOI: 10.1111/J.1600-065X.2007.00532.X  0.355
2007 Kasirer-Friede A, Moran B, Nagrampa-Orje J, Swanson K, Ruggeri ZM, Schraven B, Neel BG, Koretzky G, Shattil SJ. ADAP is required for normal αIIbβ3 activation by VWF/GP Ib-IX-V and other agonists Blood. 109: 1018-1025. PMID 17003372 DOI: 10.1182/Blood-2006-05-022301  0.339
2004 Shattil SJ, Newman PJ. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood. 104: 1606-15. PMID 15205259 DOI: 10.1182/blood-2004-04-1257  0.316
2002 Wonerow P, Obergfell A, Wilde JI, Bobe R, Asazuma N, Brdička T, Leo A, Schraven B, Hořejší V, Shattil SJ, Watson SP. Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cγ2 regulation in platelets Biochemical Journal. 364: 755-765. PMID 12049640 DOI: 10.1042/BJ20020128  0.333
2002 Obergfell A, Eto K, Mocsai A, Buensuceso C, Moores SL, Brugge JS, Lowell CA, Shattil SJ. Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton. The Journal of Cell Biology. 157: 265-75. PMID 11940607 DOI: 10.1083/Jcb.200112113  0.302
2002 Judd BA, Myung PS, Obergfell A, Myers EE, Cheng AM, Watson SP, Pear WS, Allman D, Shattil SJ, Koretzky GA. Differential requirement for LAT and SLP-76 in GPVI versus T cell receptor signaling. The Journal of Experimental Medicine. 195: 705-17. PMID 11901197 DOI: 10.1084/Jem.20011583  0.314
1999 Shiraga M, Ritchie A, Aidoudi S, Baron V, Wilcox D, White G, Ybarrondo B, Murphy G, Leavitt A, Shattil S. Primary Megakaryocytes Reveal a Role for Transcription Factor Nf-E2 in Integrin αiibβ3 Signaling Journal of Cell Biology. 147: 1419-1430. PMID 10613901 DOI: 10.1083/Jcb.147.7.1419  0.375
1991 Shattil S. Use of monoclonal antibodies for the detection and analysis of activated human platelets. Current Studies in Hematology and Blood Transfusion. 58: 26-31. PMID 1954770 DOI: 10.1159/000419332  0.327
1990 Abrams C, Ellison N, Budzynski A, Shattil S. Direct detection of activated platelets and platelet-derived microparticles in humans Blood. 75: 128-138. DOI: 10.1182/Blood.V75.1.128.Bloodjournal751128  0.429
1989 Shattil S, Budzynski A, Scrutton M. Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists. Blood. 73: 150-158. DOI: 10.1182/Blood.V73.1.150.Bloodjournal731150  0.416
1986 Shattil SJ, Motulsky HJ, Insel PA, Flaherty L, Brass LF. Expression of fibrinogen receptors during activation and subsequent desensitization of human platelets by epinephrine. Blood. 68: 1224-31. PMID 3779100 DOI: 10.1182/Blood.V68.6.1224.1224  0.42
1985 Shattil S, Brass L, Bennett J, Pandhi P. Biochemical and functional consequences of dissociation of the platelet membrane glycoprotein IIb-IIIa complex Blood. 66: 92-98. DOI: 10.1182/Blood.V66.1.92.92  0.392
1982 Shattil S, Montgomery J, Chiang P. The effect of pharmacologic inhibition of phospholipid methylation on human platelet function. Blood. 59: 906-912. DOI: 10.1182/Blood.V59.5.906.906  0.391
1981 Shattil S, McDonough M, Burch J. Inhibition of platelet phospholipid methylation during platelet secretion Blood. 57: 537-544. DOI: 10.1182/Blood.V57.3.537.Bloodjournal573537  0.375
Show low-probability matches.